Physician profile
Jon Allmon
NPI 1831174044
$5,804.50
in general payments reported to CMS, 2019-2025
21 companies · $587 in 2025
The $587 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,261 · 2020: $201 · 2021: $223 · 2022: $374 · 2023: $531 · 2024: $628 · 2025: $587.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,567 · Travel and Lodging: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,567.11 |
| Travel and Lodging | $179.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,899.70 | 2019-2020 | |
| Medtronic Vascular, INC. | $1,027.96 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $829.08 | 2019-2025 | Venclose Maven Catheter, Venovo |
| Boston Scientific Corporation | $492.31 | 2020-2025 | Varithena Administration Pack |
| W. L. Gore & Associates, INC. | $391.25 | 2019-2024 | Gore Viabahn Vbx Balloon Expandable Endo |
| Janssen Pharmaceuticals, INC | $265.57 | 2019-2023 | Xarelto |
| Tactile Systems Technology INC | $159.15 | 2025 | Nimbl, Flexitouch Plus |
| Stability Biologics, LLC | $141.97 | 2022 | |
| Cashflow Solutions, LLC | $120.51 | 2022-2025 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Organogenesis INC. | $117.00 | 2022-2024 | Puraply |
| Venclose INC. | $87.85 | 2020 | |
| Progenacare Global, LLC | $79.81 | 2023 | |
| Smith+Nephew, INC. | $45.44 | 2019-2025 | Collagenase Santyl |
| Angiodynamics, INC. | $33.71 | 2019 | |
| Pfizer INC. | $27.70 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $22.26 | 2023 | Venaseal |
| Aroa Biosurgery Incorporated | $21.58 | 2024 | |
| Kerecis Limited | $15.78 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Lemaitre Vascular, INC. | $12.73 | 2019 | |
| Cardiovascular Systems INC. | $9.31 | 2019 | |
| Penumbra, INC. | $3.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Allmon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.